These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21082971)

  • 21. Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation.
    Chiaretti S; Li X; Gentleman R; Vitale A; Wang KS; Mandelli F; Foà R; Ritz J
    Clin Cancer Res; 2005 Oct; 11(20):7209-19. PubMed ID: 16243790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement.
    Baeumler J; Szuhai K; Falkenburg JH; van Schie ML; Ottmann OG; Nijmeijer BA
    Cancer Genet Cytogenet; 2008 Aug; 185(1):37-42. PubMed ID: 18656692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
    Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
    Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
    Williams RT; Sherr CJ
    Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
    Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
    Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL.
    Mullighan CG; Williams RT; Downing JR; Sherr CJ
    Genes Dev; 2008 Jun; 22(11):1411-5. PubMed ID: 18519632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M
    J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in significance of drug resistance mechanisms between adult and childhood acute lymphoblastic leukemia.
    Styczyński J; Wysocki M
    Haematologia (Budap); 2002; 32(4):313-25. PubMed ID: 12803106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond Philadelphia: 'Ph-like' B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises.
    Izraeli S
    Curr Opin Hematol; 2014 Jul; 21(4):289-96. PubMed ID: 24848770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.
    Iacobucci I; Lonetti A; Messa F; Ferrari A; Cilloni D; Soverini S; Paoloni F; Arruga F; Ottaviani E; Chiaretti S; Messina M; Vignetti M; Papayannidis C; Vitale A; Pane F; Piccaluga PP; Paolini S; Berton G; Baruzzi A; Saglio G; Baccarani M; Foà R; Martinelli G
    Leukemia; 2010 Jan; 24(1):66-73. PubMed ID: 19759560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated analysis of gene copy number, copy neutral LOH, and microRNA profiles in adult acute lymphoblastic leukemia.
    Ninomiya S; Tyybäkinoja A; Borze I; Räty R; Saarinen-Pihkala UM; Usvasalo A; Elonen E; Knuutila S
    Cytogenet Genome Res; 2012; 136(4):246-55. PubMed ID: 22456238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.
    Davidsson J; Paulsson K; Lindgren D; Lilljebjörn H; Chaplin T; Forestier E; Andersen MK; Nordgren A; Rosenquist R; Fioretos T; Young BD; Johansson B
    Leukemia; 2010 May; 24(5):924-31. PubMed ID: 20237506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.
    Iacobucci I; Roberts KG
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34062932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.
    Safavi S; Hansson M; Karlsson K; Biloglav A; Johansson B; Paulsson K
    Haematologica; 2015 Jan; 100(1):55-61. PubMed ID: 25261097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
    Roberts KG; Li Y; Payne-Turner D; Harvey RC; Yang YL; Pei D; McCastlain K; Ding L; Lu C; Song G; Ma J; Becksfort J; Rusch M; Chen SC; Easton J; Cheng J; Boggs K; Santiago-Morales N; Iacobucci I; Fulton RS; Wen J; Valentine M; Cheng C; Paugh SW; Devidas M; Chen IM; Reshmi S; Smith A; Hedlund E; Gupta P; Nagahawatte P; Wu G; Chen X; Yergeau D; Vadodaria B; Mulder H; Winick NJ; Larsen EC; Carroll WL; Heerema NA; Carroll AJ; Grayson G; Tasian SK; Moore AS; Keller F; Frei-Jones M; Whitlock JA; Raetz EA; White DL; Hughes TP; Guidry Auvil JM; Smith MA; Marcucci G; Bloomfield CD; Mrózek K; Kohlschmidt J; Stock W; Kornblau SM; Konopleva M; Paietta E; Pui CH; Jeha S; Relling MV; Evans WE; Gerhard DS; Gastier-Foster JM; Mardis E; Wilson RK; Loh ML; Downing JR; Hunger SP; Willman CL; Zhang J; Mullighan CG
    N Engl J Med; 2014 Sep; 371(11):1005-15. PubMed ID: 25207766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of drug resistance in acute lymphoblastic leukemia].
    Inukai T
    Rinsho Ketsueki; 2016; 57(10):2022-2028. PubMed ID: 27795510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Fielding AK
    Hematology Am Soc Hematol Educ Program; 2011; 2011():231-7. PubMed ID: 22160039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.
    Kuiper RP; Schoenmakers EF; van Reijmersdal SV; Hehir-Kwa JY; van Kessel AG; van Leeuwen FN; Hoogerbrugge PM
    Leukemia; 2007 Jun; 21(6):1258-66. PubMed ID: 17443227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols.
    Ribera JM; García O; Fernández-Abellán P; Lavilla E; Bernal MT; González-Campos J; Brunet S; Monteserín MC; Montesinos P; Sarrá J; Calbacho M; Alvarez-Larrán A; Tormo M; Oriol A;
    Br J Haematol; 2012 Nov; 159(4):485-8. PubMed ID: 22966847
    [No Abstract]   [Full Text] [Related]  

  • 40. Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.
    Okamoto R; Ogawa S; Nowak D; Kawamata N; Akagi T; Kato M; Sanada M; Weiss T; Haferlach C; Dugas M; Ruckert C; Haferlach T; Koeffler HP
    Haematologica; 2010 Sep; 95(9):1481-8. PubMed ID: 20435627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.